S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Critical asset just had biggest fall on record (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
Domino’s stock or Papa John’s? Follow price action to find out
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Critical asset just had biggest fall on record (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
Domino’s stock or Papa John’s? Follow price action to find out
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Critical asset just had biggest fall on record (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
Domino’s stock or Papa John’s? Follow price action to find out
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Critical asset just had biggest fall on record (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
Domino’s stock or Papa John’s? Follow price action to find out

Olema Pharmaceuticals (OLMA) News Today

$13.53
+0.04 (+0.30%)
(As of 02/26/2024 ET)
SourceHeadline
MarketBeat logoOlema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - February 26 at 3:30 AM
MarketBeat logoBrokers Offer Predictions for Olema Pharmaceuticals, Inc.'s FY2023 Earnings (NASDAQ:OLMA)
americanbankingnews.com - February 26 at 1:30 AM
MarketBeat logoOlema Pharmaceuticals, Inc. (NASDAQ:OLMA) to Post FY2028 Earnings of $4.08 Per Share, Capital One Financial Forecasts
americanbankingnews.com - February 24 at 3:54 AM
MarketBeat logoCapital One Financial Reiterates "Overweight" Rating for Olema Pharmaceuticals (NASDAQ:OLMA)
americanbankingnews.com - February 24 at 1:38 AM
marketbeat.com logoCapital One Financial Comments on Olema Pharmaceuticals, Inc.'s FY2028 Earnings (NASDAQ:OLMA)
marketbeat.com - February 23 at 8:22 AM
marketbeat.com logoAcadian Asset Management LLC Sells 86,428 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
marketbeat.com - February 23 at 7:35 AM
marketbeat.com logoOlema Pharmaceuticals' (OLMA) Overweight Rating Reiterated at Capital One Financial
marketbeat.com - February 23 at 6:35 AM
finance.yahoo.com logoOLMA Mar 2024 20.000 call
finance.yahoo.com - February 17 at 10:44 AM
finance.yahoo.com logoOLMA Mar 2024 10.000 put
finance.yahoo.com - February 17 at 10:44 AM
marketbeat.com logoVictory Capital Management Inc. Purchases New Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
marketbeat.com - February 15 at 4:34 AM
marketbeat.com logoVivo Capital LLC Acquires 534,433 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
marketbeat.com - February 6 at 1:39 PM
marketbeat.com logoOlema Pharmaceuticals, Inc. (NASDAQ:OLMA) Director Sells $305,750.00 in Stock
marketbeat.com - February 2 at 6:39 PM
marketbeat.com logoOlema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Average Recommendation of "Buy" from Brokerages
marketbeat.com - February 1 at 3:30 AM
marketbeat.com logoOlema Pharmaceuticals (NASDAQ:OLMA) Shares Gap Up to $11.62
marketbeat.com - January 30 at 12:52 PM
marketbeat.com logoOlema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Citigroup
marketbeat.com - January 30 at 8:23 AM
finance.yahoo.com logoOlema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate
finance.yahoo.com - January 8 at 1:03 PM
seekingalpha.com logoOlema Pharmaceuticals: Oral SERD Developer With Interesting Data
seekingalpha.com - January 3 at 2:20 PM
marketbeat.com logoOlema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update
marketbeat.com - January 2 at 8:33 PM
finance.yahoo.com logoOlema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 2 at 7:09 PM
benzinga.com logoOlema Pharmaceuticals Stock (NASDAQ:OLMA) Dividends: History, Yield and Dates
benzinga.com - December 23 at 12:50 PM
insidermonkey.com logoHedge Fund and Insider Trading News: 3G Capital, Elliott Management, Harbor Capital, Three Arrows Capital, Nucor Corporation (NUE), Olema Pharmaceuticals, Inc. (OLMA), and More
insidermonkey.com - December 21 at 12:04 PM
marketbeat.com logoShort Interest in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Rises By 88.8%
marketbeat.com - December 13 at 11:40 PM
marketbeat.com logoKynam Capital Management LP Decreases Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
marketbeat.com - December 11 at 9:40 AM
markets.businessinsider.com logoBuy Rating on Olema Pharmaceuticals: Strong Safety Profile and Market Positioning
markets.businessinsider.com - December 8 at 8:13 AM
markets.businessinsider.com logoBuy Rating Affirmed for Olema Pharmaceuticals Amid Positive Combination Therapy Study Outcomes
markets.businessinsider.com - December 6 at 11:49 PM
markets.businessinsider.com logoAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Olema Pharmaceuticals (OLMA) and InMode (INMD)
markets.businessinsider.com - December 6 at 11:49 PM
msn.com logoOlema posts Phase 1/2 data for lead asset in breast cancer
msn.com - December 5 at 7:00 PM
finance.yahoo.com logoOlema Oncology Announces Palazestrant Demonstrates Attractive Combinability with CDK4/6 Inhibitors Ribociclib and Palbociclib in Phase 1b/2 Studies
finance.yahoo.com - December 5 at 2:00 PM
finance.yahoo.com logoTop Stocks for December 2023
finance.yahoo.com - December 1 at 12:44 PM
markets.businessinsider.com logoBuy Rating Affirmed for Olema Pharmaceuticals Amidst Upcoming Data Releases and Strategic Drug Development Progress
markets.businessinsider.com - November 28 at 11:12 PM
finance.yahoo.com logoOlema Oncology to Present New Palazestrant Clinical Data in Combination with CDK4/6 Inhibitors at the 2023 San Antonio Breast Cancer Symposium (SABCS)
finance.yahoo.com - November 28 at 6:12 PM
seekingalpha.com logoOlema Pharmaceuticals: Advancing On Multiple Fronts
seekingalpha.com - November 28 at 11:52 AM
finance.yahoo.com logoThis Small Cap Is My Stock Pick, as the Market Shakes Its Hangover
finance.yahoo.com - November 27 at 12:05 PM
finance.yahoo.com logoOlema Stock Has Soared 551% This Year. Its CEO Thinks It's Still Undervalued.
finance.yahoo.com - November 22 at 2:45 PM
markets.businessinsider.com logoPromising Developments Bolster Buy Rating for Olema Pharmaceuticals: An Analysis of New Data, Collaborations, and Upcoming Studies
markets.businessinsider.com - November 8 at 11:30 PM
finance.yahoo.com logoOlema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - November 7 at 8:34 PM
finance.yahoo.com logoOlema Oncology to Participate in Upcoming Investor Conferences in November
finance.yahoo.com - November 1 at 7:10 PM
msn.com logoOlema Pharmaceuticals (OLMA) Price Target Increased by 13.64% to 25.50
msn.com - November 1 at 9:09 AM
finance.yahoo.com logoOlema Pharmaceuticals, Inc. (OLMA) Is a Great Choice for 'Trend' Investors, Here's Why
finance.yahoo.com - October 30 at 1:40 PM
finance.yahoo.com logoOlema Pharmaceuticals, Inc.'s (NASDAQ:OLMA) high hedge funds ownership speaks for itself as stock continues to impress, up 24% over last week
finance.yahoo.com - October 28 at 1:47 PM
finance.yahoo.com logo12 Best Performing NASDAQ Stocks in 2023
finance.yahoo.com - October 26 at 12:22 PM
markets.businessinsider.com logoPromising Prospects for Olema Pharmaceuticals: Buy Rating Justified by Palazestrant’s Efficacy and Market Performance
markets.businessinsider.com - October 24 at 10:35 PM
finance.yahoo.com logoOlema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant
finance.yahoo.com - October 22 at 8:54 AM
finance.yahoo.com logoOlema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors
finance.yahoo.com - October 17 at 9:55 AM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Legend Biotech (LEGN), Staar Surgical (STAA)
markets.businessinsider.com - October 16 at 9:11 AM
finance.yahoo.com logoOlema Oncology Announces Phase 2 Monotherapy Clinical Results to be Presented at the 2023 ESMO Congress
finance.yahoo.com - October 16 at 9:11 AM
finance.yahoo.com logoOlema Oncology KAT6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity
finance.yahoo.com - October 12 at 8:11 AM
finance.yahoo.com logoHere's Why Momentum in Olema Pharmaceuticals, Inc. (OLMA) Should Keep going
finance.yahoo.com - October 11 at 4:09 PM
finance.yahoo.com logoWall Street Analysts Believe Olema Pharmaceuticals, Inc. (OLMA) Could Rally 76.47%: Here's is How to Trade
finance.yahoo.com - October 11 at 4:09 PM
markets.businessinsider.com logoBuy Rating for Olema Pharmaceuticals: Promising Progress in Palazestrant and Ribociclib Breast Cancer Trial
markets.businessinsider.com - October 11 at 9:32 AM
Get Olema Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for OLMA and its competitors with MarketBeat's FREE daily newsletter.



OLMA Media Mentions By Week

OLMA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OLMA
News Sentiment

0.94

0.45

Average
Medical
News Sentiment

OLMA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OLMA Articles
This Week

13

2

OLMA Articles
Average Week

Get Olema Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for OLMA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:OLMA) was last updated on 2/27/2024 by MarketBeat.com Staff